Wenbin Jiang, Ph.D., is a distinguished leader in the biotechnology industry, currently serving as the Chief Executive Officer and President of Cytek Biosciences Inc. Dr. Jiang co-founded Cytek Biosciences in 2014, driven by a vision to revolutionize flow cytometry and enhance the capabilities of life science researchers worldwide. His academic journey began with a Bachelor of Science degree in Biochemistry from Fudan University in Shanghai, followed by a Ph.D. in Immunology from the University of Chicago. His deep understanding of immunology and biochemistry has been instrumental in guiding Cytek's development of cutting-edge technologies. Prior to founding Cytek Biosciences, Dr. Jiang held several key positions that honed his expertise and leadership skills. He worked as a Senior Scientist at Becton Dickinson (BD) Biosciences, where he contributed significantly to the development of innovative flow cytometry products. His tenure at BD Biosciences was marked by notable advancements in multi-color flow cytometry, which laid the groundwork for his future endeavors. At Cytek Biosciences, Dr. Jiang has been pivotal in steering the company towards becoming a leader in spectral flow cytometry. Under his leadership, Cytek has successfully launched the Aurora and Northern Lights systems, which have set new standards in the field by offering unprecedented resolution and sensitivity. As CEO and President, Dr. Jiang continues to drive Cytek Biosciences' mission to empower researchers with advanced tools that accelerate scientific discovery. His strategic vision has led to significant growth and expansion for the company, including its successful IPO in 2021. Dr. Jiang's commitment to innovation and excellence is evident in Cytek's ongoing development of new technologies and applications, ensuring that the company remains at the forefront of the flow cytometry industry. His leadership not only fosters a culture of scientific excellence but also positions Cytek Biosciences as a key player in advancing global biomedical research.